IPR2016-00383
`Petitioner's Updated Exhibit List
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________________________________________
`
`GENZYME CORPORATION,
`Petitioner
`v.
`
`GENENTECH, INC. AND CITY OF HOPE,
`Patent Owners
`
`Case No. IPR2016-00383
`U. S. Patent No. 6,331,415
`
`Petitioner's Updated Exhibit List
`
`1
`
`
`Petitioner's Updated Exhibit List
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________________________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________________________________________
`
`GENZYME CORPORATION,
`Petitioner
`v.
`
`GENENTECH, INC. AND CITY OF HOPE,
`Patent Owners
`
`Case No. IPR2016-00383
`U. S. Patent No. 6,331,415
`
`Petitioner's Updated Exhibit List
`
`1
`
`
`
`Exhibit
`No.
`
`1001
`
`1002
`
`1003
`
`1004
`
`1005
`
`1006
`
`1007
`
`1008
`
`1009
`
`1010
`
`1011
`
`EXHIBIT LIST
`
`Description
`
`U.S. Patent No. 6,331,415
`
`U.S. Patent No. 4,495,280
`
`Abbreviation
`
`'415 patent
`
`Salser, or the Salser patent
`
`Ochi et al., Transfer of a Cloned
`Immunoglobulin Light-Chain Gene to
`Mutant Hybridoma Cells Restores
`Specific Antibody Production, Nature,
`302:340-342 (1983)
`Southern and Berg, Transformation of
`Mammalian Cells to Antibiotic
`Resistance with a Bacterial Gene Under
`Control of the SV40 Early Region
`Promoter, Journal of Molecular and
`Applied Genetics, 1:327-41 (1982)
`U.S. Patent No. 4,816,657
`
`'415 reexamination, Ex Parte
`Reexamination Certificate
`
`U.S. Patent No. 4,816,397
`
`Final Order After District Court
`Judgment, Patent Interference 102,572,
`Paper No. 70 (Jul. 25, 2001)
`
`Ochi (I)
`
`Southern
`
`Cabilly I patent
`
`Reexam Cert.
`
`Boss patent
`
`Interference Final Order
`
`'415 patent reexamination, Appeal Brief
`
`Appeal Br.
`
`Alberts et al., Molecular Biology of the
`Cell (1983) (excerpts)
`
`Huber, Spatial Structure of
`Immunoglobulin Molecules, Klinische
`Wochenschrift, 58:1217-31 (1980)
`
`Alberts (1983)
`
`Huber
`
`720578303
`
`2
`
`
`
`1012
`
`National Library of Medicine, Medical
`Subject Headings Tree Structures, 1984
`(excerpts)
`
`1013
`
`Kuby, Immunology (2007) (excerpts)
`
`Malcolm et al., Localization of Human
`Immunoglobulin κ Light Chain Variable
`Region Genes to the Short Arm of
`Chromosome 2 by in Situ Hybridization,
`Proceedings of the National Academy of
`Sciences USA, 79:4957-61 (1982)
`
`'415 patent reexamination, Owners'
`Resp. dated 11/25/05
`
`'415 patent reexamination, Owners'
`Resp. dated 10/30/06
`
`Harris, Expression of Eukaryotic Genes
`in E. Coli, in Genetic Engineering 4,
`127-185 (1983)
`
`'415 patent reexamination, Declaration
`of Dr. Timothy John Roy Harris under
`37 C.F.R. § 1.132
`
`MeSH
`
`Kuby
`
`Malcolm
`
`Owners' Resp. (11/25/05)
`
`Owners' Resp. (10/30/06)
`
`Harris
`
`Harris Decl.
`
`1014
`
`1015
`
`1016
`
`1017
`
`1018
`
`1019
`
`1020
`
`1021
`
`1022
`
`'415 patent reexamination, Office Action
`dated 2/16/07
`
`Office Action (2/16/07)
`
`'415 patent reexamination, Owners'
`Resp. dated 5/21/07
`
`Owners' Resp. (5/21/07)
`
`U.S. Patent No. 4,399,216
`
`Axel, or the Axel patent
`
`Colaianni and Cook-Deegan, Columbia
`University's Axel Patents: Technology
`Transfer and Implications for the Bayh-
`Dole Act, The Milbank Quarterly,
`87:683-715 (2009)
`
`Colaianni
`
`720578303
`
`3
`
`
`
`1023
`
`1024
`
`1025
`
`1026
`
`1027
`
`1028
`
`1029
`
`1030
`
`1031
`
`1032
`
`1033
`
`Rigby and Shenk, Paul Berg, on His
`65th Birthday, Nucleic Acids Research,
`19:7041 (1991)
`
`Rice and Baltimore, Regulated
`Expression of an Immunoglobulin K
`Gene Introduced into a Mouse Lymphoid
`Cell Line, Proceedings of the National
`Academy of Sciences USA, 79:7862-65
`(1982)
`
`Oi et al., Immunoglobulin Gene
`Expression in Transformed Lymphoid
`Cells, Proceedings of the National
`Academy of Sciences USA, 80:825-829
`(1983)
`
`Kabat et al., Sequences of Proteins of
`Immunological Interest (1983) (excerpt)
`
`Rigby
`
`Rice
`
`Oi
`
`Kabat
`
`'415 patent reexamination, Final Office
`Action dated 2/25/08
`
`Final Office Action
`(2/25/08)
`
`'415 patent reexamination, Owners'
`Resp. dated 6/6/08
`
`Owners' Resp. (6/6/08)
`
`U.S. Patent No. 4,237,224
`
`Cohen & Boyer patent
`
`Cline, Research on Gene Therapy, in
`Basic Biology of New Developments in
`Biotechnology, 77-92 (1983)
`
`Alberts et al., Molecular Biology of the
`Cell (2002) (excerpts)
`
`Efstratiadis et al., The Structure and
`Evolution of the Human β-Globin Gene
`Family, Cell, 21:653-68 (1980)
`
`Rogers et al., Sequence Analysis of
`Cloned cDNA Encoding Part of an
`Immunoglobulin Heavy Chain, Nucleic
`
`Cline
`
`Alberts (2002)
`
`Efstratiadis
`
`Rogers
`
`720578303
`
`4
`
`
`
`Acids Research, 6:3305-21 (1979)
`
`Strathearn et al., Characterization of an
`Immunoglobin cDNA Clone Containing
`the Variable and Constant Regions for
`the MOPC 21 Kappa Light Chain,
`Nucleic Acids Research, 5:3101-11
`(1978)
`
`Ochi et al., Functional Immunoglobulin
`M Production after Transfection of
`Cloned Immunoglobulin Heavy and
`Light Chain Genes into Lymphoid Cells,
`Proceedings of the National Academy of
`Sciences USA, 80:6351-55 (1983)
`
`Cattaneo and Neuberger, Polymeric
`Immunoglobulin M is Secreted by
`Transfectants of Nonlymphoid Cells in
`the Absence of Immunoglobulin J Chain,
`The EMBO Journal, 6:2753-58 (1987)
`
`Daugherty et al., Polymerase Chain
`Reaction Facilitates the Cloning, CDR-
`Grafting, and Rapid Expression of a
`Murine Monoclonal Antibody Directed
`Against the CD18 Component of
`Leukocyte Integrins, Nucleic Acids
`Research, 19:2471-76 (1991)
`Bruynck et al., Characterisation of a
`Humanised Bispecific Monoclonal
`Antibody for Cancer Therapy, British
`Journal of Cancer, 67:436-40 (1993)
`Reichart, Marketed Therapeutic
`Antibodies Compendium, mAbs, 4:413-
`15 (2012)
`
`Beidler et al., Cloning and High Level
`Expression of a Chimeric Antibody with
`Specificity for Human Carcinoembryonic
`
`1034
`
`1035
`
`1036
`
`1037
`
`1038
`
`1039
`
`1040
`
`720578303
`
`5
`
`Strathearn
`
`Ochi (II)
`
`Cattaneo
`
`Daugherty
`
`Bruynck
`
`Reichert
`
`Beidler
`
`
`
`Antigen, Journal of Immunology,
`141:4053-60 (1988)
`
`Sahagan et al., A Genetically Engineered
`Murine/Human Chimeric Antibody
`Retains Specificity for Human Tumor-
`Associated Antigen, Journal of
`Immunology, 137:1066-74 (1986)
`
`Nishimura et al., Recombinant Human-
`Mouse Chimeric Monoclonal Antibody
`Specific for Common Acute Lymphocytic
`Leukemia Antigen, Cancer Research,
`47:999-1005 (1987)
`
`Komori et al., Production of Heavy-
`Chain Class-Switch Variants of Human
`Monoclonal Antibody by Recombinant
`DNA Technology, Clinical &
`Experimental Immunology, 71:508-16
`(1988)
`
`Sahagan
`
`Nishimura
`
`Komori
`
`Final Decision, Patent Interference
`102,572, Paper No. 57 (Jul. 6, 1998)
`
`Interference Final
`Decision
`
`MedImmune, Inc. v. Genentech, Inc., No.
`03-02567 (C.D. Cal. Aug. 17, 2007),
`Expert Report of E. Fintan Walton
`
`Complaint in MedImmune v. Genentech,
`No. 03-02567 (C.D. Cal.)
`
`Stipulation and order of dismissal in
`MedImmune v. Genentech, No. 03-02567
`(C.D. Cal.)
`
`Complaint in Centocor v. Genentech,
`No. 08-CV-3573 (C.D. Cal.)
`
`Order of dismissal in Centocor v.
`Genentech, No. 08-CV-3573 (C.D. Cal.)
`
`Walton Expert Rep.
`
`-
`
`-
`
`-
`
`-
`
`1041
`
`1042
`
`1043
`
`1044
`
`1045
`
`1046
`
`1047
`
`1048
`
`1049
`
`720578303
`
`6
`
`
`
`1050
`
`1051
`
`1052
`
`1053
`
`1054
`
`1055
`
`1056
`
`1057
`
`1058
`
`1059
`
`1060
`
`1061
`
`Complaint in Glaxo Group Ltd. v.
`Genentech, No. 10-02764 (C.D. Cal.)
`
`Order of dismissal in Glaxo Group Ltd.
`v. Genentech, No. 10-02764 (C.D. Cal.)
`
`Complaint in Human Genome Sciences
`v. Genentech, No. 11-CV-6519 (C.D.
`Cal.)
`
`Order of dismissal in Human Genome
`Sciences v. Genentech, No. 11-CV-6519
`(C.D. Cal.)
`
`Complaint in Eli Lilly and ImClone
`Systems LLC v. Genentech, No. 13-CV-
`7248 (C.D. Cal.)
`
`Stipulation of dismissal in Eli Lilly and
`ImClone Systems LLC v. Genentech, No.
`13-CV-7248 (C.D. Cal.)
`
`Complaint in Bristol-Myers Squibb v.
`Genentech, No. 13-CV-5400 (C.D. Cal.)
`
`Stipulation of dismissal in Bristol-Myers
`Squibb v. Genentech, No. 13-CV-5400
`(C.D. Cal.)
`
`Declaration of Margaret H. Baron, M.D.,
`Ph.D., in Support of Genzyme's Petition
`for Inter Partes Review of U.S. Patent
`No. 6,331,415
`
`Declaration of Lisa M. Ferri in Support
`of Motion to Appear Pro Hac Vice on
`Behalf of Petitioner
`
`Professional Profile of Lisa M. Ferri
`
`Declaration of Timothy Creagan in
`Support of Petitioner’s Reply to Patent
`
`720578303
`
`7
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`-
`
`Baron Decl.
`
`-
`
`-
`
`Creagan Decl.
`
`
`
`Owner’s Preliminary Response
`
`720578303
`
`8
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
